News & Events
Enhancing global collaboration for earlier detection and prevention of MS
Research priorities identified to help better understand the MS prodrome
Solving the mystery of progression: the key to new treatments for progressive MS
Catch up with the latest webcast on unraveling the mystery of progression and identifying new targets for…
10-year Intersectoral global plan approved to improve care for people affected by neurological conditions
MSIF supports the adoption of the WHO's intersectoral global action plan on epilepsy and other neurological disorders,…
Global webcast on ending progressive MS
Learn about important, new research initiatives that will fuel the development of breakthrough treatments for progressive MS.…
How do we improve MS research and care? Let’s act on what people affected by MS are telling us
The global PROMS initiative publishes its plans for realising the full potential of patient reported outcomes for…
An update from the MS Global Data Sharing Initiative – Thank You!
When we come together, we can find answers, quickly, to global MS challenges.
Results of the MS research priority survey for Cochrane systematic reviews
The research questions identified as priority topics by over 1000 people affected by MS and healthcare professionals
Patent status of MS disease-modifying therapies (DMTs) around the world
Collaborating with the Medicines Patent Pool as MSIF continues work on improving access to MS treatments
Tawasol – March 2022 issue
Your update from MS organisations in the Arab Region
Could a blood test measuring Neurofilament light chain levels predict future MS activity?
A study funded by the International Progressive MS Alliance shows a blood test may have potential in…
Making information on caregiving more accessible
Adapting the MS Society of India’s ‘Guide for MS Caregivers’ for a global audience.
What treatments are approved for children and young people with MS?
We look into these in more detail to understand how the treatment decisions are made by regulators.